These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8895066)

  • 21. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits.
    Wernette-Hammond ME; Garcia Z; Arnold KS; Innerarity TL
    Arteriosclerosis; 1989; 9(4):501-10. PubMed ID: 2546526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected inhibition of cholesterol 7 alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits.
    Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Parker TS; Chen TS; Zhao Z; Donnelly TM; Tint GS
    J Clin Invest; 1995 Apr; 95(4):1497-504. PubMed ID: 7706454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits.
    Hornick CA; Kita T; Hamilton RL; Kane JP; Havel RJ
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6096-100. PubMed ID: 6577469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recapture of hepatic apolipoprotein B mRNA editing may be a promising strategy to relieve nephrotic dyslipidemia.
    Hu P; Lu L; Hu B; Qin YH
    Med Hypotheses; 2010 Dec; 75(6):561-3. PubMed ID: 20705399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased removal of beta-very low density lipoproteins after ethinyl estradiol is associated with increased mRNA levels for hepatic lipase, lipoprotein lipase, and the low density lipoprotein receptor in Watanabe heritable hyperlipidemic rabbits.
    Demacker PN; Staels B; Stalenhoef AF; Auwerx J
    Arterioscler Thromb; 1991; 11(6):1652-9. PubMed ID: 1657130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
    Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
    J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
    de Roos B; Caslake MJ; Milliner K; Benson GM; Suckling KE; Packard CJ
    Atherosclerosis; 2005 Jul; 181(1):63-8. PubMed ID: 15939055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
    Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.
    Yamada N; Shames DM; Havel RJ
    J Clin Invest; 1987 Aug; 80(2):507-15. PubMed ID: 3611356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apobec-1 and apolipoprotein B mRNA editing.
    Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
    Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
    Greeve J; Axelos D; Welker S; Schipper M; Greten H
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
    Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway.
    Hussain MM; Innerarity TL; Brecht WJ; Mahley RW
    J Biol Chem; 1995 Apr; 270(15):8578-87. PubMed ID: 7721759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
    Lau PP; Chan L
    J Biol Chem; 2003 Dec; 278(52):52988-96. PubMed ID: 14559896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Tanaka M; Otani H; Yokode M; Kita T
    Atherosclerosis; 1995 Apr; 114(1):73-82. PubMed ID: 7605378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA.
    Srivastava RA
    Biochem Biophys Res Commun; 1995 Jul; 212(2):381-7. PubMed ID: 7626051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice.
    Chirieac DV; Davidson NO; Sparks CE; Sparks JD
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G382-8. PubMed ID: 16798720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.